We are live on ! Find out more
FSTX

F-star Therapeutics, Inc. Common Stock
FSTX

Delisted

FSTX was delisted on the 8th of March, 2023.

Back to rankings

59 hedge funds and large institutions have $57.8M invested in F-star Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

63% more capital invested

Capital invested by funds: $35.5M → $57.8M (+$22.3M)

9% more funds holding

Funds holding: 54 → 59 (+5)

47% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 19

93% less call options, than puts

Call options by funds: $331K | Put options by funds: $4.8M

Holders
59
Holders Change
+5
Holders Change %
+9.26%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
10
Reduced
19
Closed
9
Calls
$331K
Puts
$4.8M
Net Calls
-$4.47M
Net Calls Change
-$3.35M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$5.54M
2
WAM
Weiss Asset Management
Massachusetts
+$3.03M
3
QOP
Quinn Opportunity Partners
Virginia
+$995K
4
VAM
Vazirani Asset Management
New York
+$692K
5
BCM
BCK Capital Management
Connecticut
+$473K

Top Sellers

Rank Fund Capital Flow
1
DMKJ
David M. Knott Jr
-$1.21M
2
AA
AlphaCentric Advisors
Puerto Rico
-$845K
3
E
Ergoteles
New York
-$760K
4
HF
HRT Financial
New York
-$558K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$324K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$398K – – –
PCM
27
Prelude Capital Management
New York
$384K +$231K +41,719 +219%
FAM
28
Formidable Asset Management
Ohio
$350K -$39.4K -7,112 -11%
TI
29
Tidal Investments
Wisconsin
$350K -$39.2K -7,078 -11%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$348K -$286K -51,670 -48%
TA
31
TLS Advisors
Florida
$343K +$301K +54,298 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$336K -$1.71K -309 -0.6%
STC
33
Sarah T. Connolly
$335K – – –
RCI
34
Ridgeback Capital Investments
Florida
$332K +$291K +52,509 New
WAM
35
Wolverine Asset Management
Illinois
$323K +$22.9K +4,137 +9%
BC
36
Brookfield Corp
Ontario, Canada
$316K +$277K +50,000 New
FFH
37
Fairfax Financial Holdings
Ontario, Canada
$312K +$138K +25,000 +102%
Man Group
38
Man Group
United Kingdom
$268K +$235K +42,411 New
Northern Trust
39
Northern Trust
Illinois
$222K – – –
PCM
40
PenderFund Capital Management
British Columbia, Canada
$195K -$19.8K -3,580 -14%
SC
41
Shay Capital
New York
$148K +$130K +23,456 New
Millennium Management
42
Millennium Management
New York
$118K +$36.2K +6,546 +54%
Squarepoint
43
Squarepoint
New York
$94.1K -$21.1K -3,805 -20%
HHGC
44
Hunting Hill Global Capital
New York
$93.3K -$66.6K -12,031 -45%
VF
45
Virtu Financial
New York
$88K +$77.1K +13,933 New
Charles Schwab
46
Charles Schwab
California
$85.9K +$75.3K +13,596 New
PCA
47
Private Capital Advisors
Connecticut
$83K – – –
SAM
48
Silvercrest Asset Management
New York
$79.5K – – –
Envestnet Asset Management
49
Envestnet Asset Management
Illinois
$69.9K -$7.39K -1,335 -11%
WSFS
50
Wilmington Savings Fund Society
Delaware
$63K – – –
1
2
3

FSTX Hedge Fund Activity: Q4 2022 in Review

59 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in F-star Therapeutics, Inc. Common Stock (FSTX) for Q4 2022, worth a combined $57.8M — up 63% from $35.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new FSTX positions and 9 closed out — a net gain of 6 holders — while 10 added to existing stakes and 19 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $5.54M. The largest seller was David M. Knott Jr, exiting entirely with an estimated $1.21M sold.

  • 59 institutional investors held F-star Therapeutics, Inc. Common Stock (FSTX) as of Q4 2022, up from 54 in Q3 2022.
  • Funds reported $57.8M of F-star Therapeutics, Inc. Common Stock stock for Q4 2022, up 63% quarter-over-quarter.
  • 15 funds opened new F-star Therapeutics, Inc. Common Stock positions in Q4 2022 and 9 closed out, a net change of +6 holders.
  • The largest F-star Therapeutics, Inc. Common Stock buyer in Q4 2022 was Armistice Capital, an estimated $5.54M added.
  • The largest F-star Therapeutics, Inc. Common Stock seller in Q4 2022 was David M. Knott Jr, an estimated $1.21M sold.

Based on aggregated 13F filings for Q4 2022.